Skip Nav Destination
Close Modal
Update search
NARROW
Format
Journal
Date
Availability
1-2 of 2
Alain Goriely
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Publisher: Journals Gateway
Network Neuroscience 1–22.
Published: 13 January 2025
Abstract
View article
PDF
Brain tumors can induce pathological changes in neuronal dynamics that are reflected in functional connectivity measures. Here, we use a whole-brain modeling approach to investigate pathological alterations to neuronal activity in glioma patients. By fitting a Hopf whole-brain model to empirical functional connectivity, we investigate glioma-induced changes in optimal model parameters. We observe considerable differences in neuronal dynamics between glioma patients and healthy controls, both on an individual and population-based level. In particular, model parameter estimation suggests that local tumor pathology causes changes in brain dynamics by increasing the influence of interregional interactions on global neuronal activity. Our approach demonstrates that whole-brain models provide valuable insights for understanding glioma-associated alterations in functional connectivity. Author Summary This study investigates how gliomas affect neuronal activity and connectivity using a whole-brain computational model. By fitting this model to empirical data, we compare glioma patients with healthy individuals to uncover significant differences in brain dynamics. Our findings indicate that local tumor pathology enhances the influence of interregional interactions on overall neuronal activity. This approach underscores the utility of whole-brain computational models in revealing the complex alterations in functional connectivity associated with gliomas, advancing our understanding of their impact on brain function.
Includes: Supplementary data
Journal Articles
Prama Putra, for the Alzheimer’s Disease Neuroimaging Initiative, Travis B. Thompson, for the Alzheimer’s Disease Neuroimaging Initiative, Pavanjit Chaggar ...
Publisher: Journals Gateway
Network Neuroscience (2021) 5 (4): 929–956.
Published: 30 November 2021
FIGURES
| View All (12)
Abstract
View article
PDF
A hallmark of Alzheimer’s disease is the aggregation of insoluble amyloid-beta plaques and tau protein neurofibrillary tangles. A key histopathological observation is that tau protein aggregates follow a structured progression pattern through the brain. Mathematical network models of prion-like propagation have the ability to capture such patterns, but a number of factors impact the observed staging result, thus introducing questions regarding model selection. Here, we introduce a novel approach, based on braid diagrams, for studying the structured progression of a marker evolving on a network. We apply this approach to a six-stage ‘Braak pattern’ of tau proteins, in Alzheimer’s disease, motivated by a recent observation that seed-competent tau precedes tau aggregation. We show that the different modeling choices, from the model parameters to the connectome resolution, play a significant role in the landscape of observable staging patterns. Our approach provides a systematic way to approach model selection for network propagation of neurodegenerative diseases that ensures both reproducibility and optimal parameter fitting. Author Summary Network diffusion models of neurodegenerative diseases are a class of dynamical systems that simulate the evolution of toxic proteins on the connectome. These models predict, from an initial seed, a pattern of invasion called staging. The generalized staging problem seeks to systematically study the effect of various model choices on staging. We introduce methods based on braid diagrams to test the possible staging landscape of a model and how it depends on the choice of connectome, as well as the model parameters. Our primary finding is that connectome construction, the choice of the graph Laplacian, and transport models all have an impact on staging that should be taken into account in any study.
Includes: Supplementary data